VERIDIANA PINHEIRO: Open Payments
NPI 1104478015 · DAVIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,588 in 83 payments from 15 companies in 2025. Trend: 2023 $1,184 · 2024 $1,342 · 2025 $1,588
Food & beverage: $1,588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $248 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $191 |
| QOL Medical, LLC | 6 | $180 |
| Janssen Biotech, Inc. | 12 | $163 |
| Madrigal Pharmaceuticals | 11 | $149 |
| Lilly USA, LLC | 5 | $100 |
| Ardelyx, Inc. | 4 | $91 |
| Ipsen Biopharmaceuticals, Inc | 4 | $87 |
| Aimmune Therapeutics, Inc. | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
Products named: Sucraid, XIFAXAN, TREMFYA, REZDIFFRA, OMVOH, CREON, IBSRELA, DUPIXENT.
Industry payments across FL — which companies pay providers there.
